左二为宏锡基金获奖代表 10月15日，主题为"固本 砺新 行远"的2025私募基金高质量发展大会在深圳举行，与该论坛同时举办的还有"国信证券杯·第十六届私募金牛奖"颁奖典礼。 金牛私募管理公司 奖杯 会上，第十六届私募金牛奖获奖私募榜单揭晓。广东宏锡基金管理有限公司荣获"金牛私募管理公司（年度管理期货策略）"。 广东宏锡基金管理有限公司，成立于2015年1月，是中国基金业协会备案登记的私募基金管理人，中国证券投资基金业协会普通会员单位(P1008245)，广 东基金业协会理事单位(P120001)，满足"3+3"投顾要求，是一家专注量化CTA的对冲基金公司。公司本着"数据说话、业绩说话"的经营理念，立志成为中 国量化CTA基金行业的领导者。 关于"私募金牛奖" 私募金牛奖是国内私募行业公认的权威奖项之一。私募金牛奖评选活动旨在建立和完善国内私募证券投资基金管理机构和投资经理的科学评价体系和交流 平台，展示私募证券投资基金行业的优秀管理机构和投资经理，彰显他们的先进理念和成功经验，提升私募证券投资基金行业的社会影响力和认知度，推 动行业规范健康发展。 评选坚持公开、公平、公正的原则，采用定量与定性相结合的方法， ...

Core Viewpoint - The article discusses the regulatory developments in quantitative trading in China's securities and futures markets, highlighting the growth and performance of quantitative CTA strategies in the private equity sector amidst market fluctuations [1][3]. Regulatory Developments - The China Securities Regulatory Commission (CSRC) introduced the "Securities Market Algorithmic Trading Management Measures" in 2024, marking the beginning of standardized development for quantitative trading in the stock market [1]. - The new regulations for algorithmic trading in the futures market, which have been in trial since June, will officially take effect on October 9 [1]. Performance of Quantitative CTA Strategies - Quantitative CTA strategies have gained popularity among investors due to their low correlation with stocks and bonds, especially in volatile market conditions [1]. - From 2021 to the end of 2024, quantitative CTA strategies significantly outperformed subjective long and quantitative long strategies during a turbulent market [1]. Year-to-Date Performance Comparison - As of September 19, 2023, the average return for 399 quantitative CTA products was 10.84%, while subjective long strategies averaged 34.59% and quantitative long strategies averaged 37.05% [3]. - Among private equity firms managing over 5 billion, the average return for quantitative CTA products was 7.63%, with 87.10% showing positive returns [3]. Top Performing Quantitative CTA Products - The article lists the top-performing quantitative CTA products for the year, with the leading product managed by 信弘天禾 (Xinhong Tianhe) achieving a return of ***% [4][5]. - Other notable products include those managed by 宏锡基金 (Hongxi Fund) and 洛书投资 (Luoshu Investment), which also performed well [4][5]. Performance in Different Fund Sizes - For private equity firms with assets between 20-50 billion, the average return for quantitative CTA products was 6.42%, with a positive return rate of 93.94% [6]. - In the 10-20 billion category, the average return was 11.04%, with a positive return rate of 97.56% [9]. - For firms managing 5-10 billion, the average return was 7.45%, with 84.21% showing positive returns [11]. - In the smallest category (0-5 billion), the average return was 14.15%, with 83.05% of products achieving positive returns [13]. Conclusion on Market Trends - The article emphasizes the potential for growth in the quantitative trading market in China, suggesting that it is still in a phase of rapid development with significant future opportunities [5].

Group 1 - The private equity investment sector is witnessing a new trend with notable firms like Waying Investment, Shanhai Fund, and Shenhan Capital venturing into short drama production, specifically a financial-themed short drama titled "Rebirth in the Millennium: My Revenge Path through Futures" [1] - The plot of the drama revolves around a billionaire private equity mogul who faces a life-altering event in 2025 due to significant market fluctuations caused by Trump's tariff announcement, leading to a financial collapse and personal tragedy, followed by a time-travel twist back to the year 2000 [1] - Waying Investment has three products with performance displays, including the quantitative CTA product "Waying Heshun Hedging No. 1," which ranks highly among its peers, although specific return data is anonymized due to regulatory requirements [1] Group 2 - The volatility and uncertainty of the futures market deter many investors, yet some private equity firms have achieved notable success in this area [2] - In the current year, Feng Shengli from Fuhua Zixin Private Equity has excelled with the subjective CTA product "Fuhua Tunquan Jinqi," showcasing his extensive investment experience and asset management skills [2] - In the quantitative CTA category, Shuanglong Investment's "Shuanglong-Longyun No. 1" has also performed exceptionally well, ranking among the top products [2] Group 3 - A list of top-performing private equity products in the current year includes "Fuhua Tunquan Jinqi" by Fuhua Zixin, "Jingsheng Tunquan Private Enjoyment" by Jingsheng Investment, and "Ruiti Futures Miracle No. 1" by Ruirui, all of which are in the subjective CTA category [3] - In the top private equity segment, "Xinhong CTA No. 1 Quantitative A Class" managed by Zhang Yi has attracted significant investor interest due to its outstanding performance [3] Group 4 - Over the past year and three years, several private equity firms and products have emerged as top performers, including Hu Qing from Xuming Investment and Xie Dong from Luoshu Investment, who have excelled in the futures market with their subjective and quantitative CTA strategies [4] - Their success is attributed to a deep understanding of the market and a stable investment style [4] Group 5 - The performance data for the past year highlights "Xuming Jingjian B Class" by Xuming Investment and "Fuhua Tunquan Jinqi" by Fuhua Zixin as leading products in the subjective CTA category [5] - Other notable products include "Jingsheng Tunquan Private Enjoyment" and "Daiying Jincheng A Class" from various private equity firms, showcasing a diverse range of strategies and performances [5]

Group 1 - The article discusses a short drama produced by three private equity firms, which is a first in the industry, focusing on a financial theme related to futures trading [1] - The plot centers around a billionaire private equity boss who faces significant losses due to market volatility and personal tragedy, leading to a narrative of rebirth and redemption through futures trading [1] - The private equity firm Woying Investment has three products displayed on the platform, with an average return of ***% as of July 25, 2025 [1][2] Group 2 - As of July 25, 2025, there are 603 futures and derivatives strategy products with a total scale of approximately 343.31 billion, with an average return of 8.73% this year [5] - Among these, 339 quantitative CTA products have an average return of 8.31%, while 156 subjective CTA products have an average return of 12.15% [5] - The top three private equity products in the futures and derivatives strategy for this year are from Beijing Fuhua Zixin, Jing Sheng Investment, and Rui Zhen Investment [5] Group 3 - The article provides rankings of private equity products based on their performance over the past year and three years, highlighting the top performers in both quantitative and subjective strategies [9][13] - The average return for futures and derivatives strategy products over the past year is 20.66%, with 328 quantitative CTA products averaging 19.07% and 145 subjective CTA products averaging 28.76% [9] - Over the past three years, the average return for these products is 61.65%, with 212 quantitative CTA products averaging 30.18% and 80 subjective CTA products averaging 74.70% [13]

Core Viewpoint - The article discusses the emergence of private equity firms engaging in creative projects, specifically the production of a short drama centered around futures trading, highlighting the challenges and uncertainties in the futures investment landscape [1] Group 1: Short Drama Production - Three private equity firms, Waying Investment, Shanhai Fund, and Shenhan Capital, have produced a short drama titled "Rebirth in the Millennium: My Revenge Path through Futures" [1] - The drama features a billionaire private equity boss who faces significant losses due to market volatility and personal tragedy, ultimately leading to a second chance in the year 2000 [1] Group 2: Performance of Private Equity Products - As of July 25, 2025, there are 603 futures and derivatives strategy products with a total scale of approximately 34.33 billion, with an average return of 8.73% this year [3] - Among these, 339 quantitative CTA products have an average return of 8.31%, while 156 subjective CTA products have an average return of 12.15% [3] Group 3: Top Performing Products - The top three futures and derivatives strategy products for the year are led by Fuhua Zixin's product, with a return of ***% [9] - In the category of private equity firms with a scale below 5 billion, the top three products are from Fuhua Zixin, Jingsheng Investment, and Ruixin Investment [10] Group 4: Recent Performance Trends - Over the past year, 573 products have shown an average return of 20.66%, with quantitative CTA products averaging 19.07% and subjective CTA products averaging 28.76% [9] - The leading products in this category are managed by Xuming Investment and Fuhua Zixin [10] Group 5: Long-Term Performance - Over the past three years, 345 products have an average return of 61.65%, with quantitative CTA products averaging 30.18% and subjective CTA products averaging 74.70% [14] - The top three products in this category are from Fuying Investment, Xuming Investment, and Ruixin Tiansuan [15]

Core Viewpoint - The A-share market has stabilized and shown a recovery in risk appetite, leading to a surge in private equity product registrations, particularly in quantitative strategies [1][2]. Private Equity Product Registration Surge - As of May 31, 2025, a total of 4,361 private equity securities products have been registered this year, marking a significant increase of 45.03% compared to the same period last year [1]. - In May alone, 870 private equity products were registered, reflecting a year-on-year growth of 77.19% [2]. - Stock strategies dominate the registered products, with 2,749 stock strategy products accounting for 63.04% of the total [2]. Market Dynamics and Investor Sentiment - High-net-worth clients are increasingly willing to enter the market through private equity channels, with significant net subscriptions reported by several firms, including a total of nearly 3 billion yuan in subscriptions for one firm [2]. - The market sentiment is improving, with the overall stock market valuation at a low point and risk premiums at historically high levels [2]. Quantitative Private Equity Products - The majority of registered products this year are from large quantitative private equity firms, with 40 out of 66 firms registering more than 10 products being large firms, and 31 of those being large quantitative firms [4]. - Quantitative private equity products have become increasingly important, with 1,930 products registered since 2025, representing 44.26% of the total private equity securities products [5]. Strategy Concentration in Quantitative Products - Within the quantitative products, stock strategies are predominant, with 1,339 stock strategy products registered, making up 69.38% of the total [5]. - The main development directions for quantitative products are index enhancement and quantitative CTA strategies [5]. Market Environment and Future Outlook - The current market environment is more active and favorable compared to last year, with high trading volumes providing more opportunities for quantitative strategies [6]. - The demand for diversified investment options is increasing among investors, contributing to the surge in private equity registrations [6].

Company Overview - Maideri Investment is a quantitative hedge fund headquartered in Paris, France, specializing in trend-following CTA strategies for over 12 years [2][4] - The parent company, Metori Capital, was founded in 2016 by Dr. Nicolas, who previously served as the global chief investment officer at a leading asset management firm, managing over €100 billion in assets [4][10] - Maideri China was established in 2019 and received its private fund license in 2020, becoming the 28th foreign and the first French private fund manager in China [4][6] Investment Strategy - The company focuses on quantitative trend-following CTA strategies, with the Chinese trend-following strategy developed independently based on the Chinese futures market [7][9] - The strategy has been operational since June 2014 in collaboration with domestic public funds, with a total scale exceeding 600 million [7] Management Scale - As of March 31, 2025, the global total management scale is approximately ¥50.21 billion, with a significant portion managed in China [6] - The assets managed under the Chinese trend-following CTA strategy reached nearly ¥2 billion by 2022 [7] Core Team - The core research and investment team has over 20 years of experience in finance and mathematics, with all members coming from leading financial institutions in China [9][16] - Dr. Guillaume Jamet, a co-CIO, has a background in mathematics and previously managed the Epsilon series fund [10][12] Achievements and Recognition - Maideri has received multiple global awards for its performance in CTA strategies over the past decade, including recognition from Hedge Fund Journal and CTA Intelligence [19] - The company has established partnerships with several leading financial institutions in China, enhancing its market presence [21]